Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518095 | SCV000612976 | benign | not specified | 2017-03-09 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000518095 | SCV000967067 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Pro222Pro in exon 11 of COL4A4: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 2.35% (200/8522) o f African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs111945121). |
Labcorp Genetics |
RCV000883099 | SCV001026379 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001141060 | SCV001301382 | benign | Alport syndrome | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000883099 | SCV001908999 | benign | not provided | 2018-07-20 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294341 | SCV002587123 | likely benign | Kidney disorder | 2020-05-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000883099 | SCV005242831 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001141060 | SCV001464048 | benign | Alport syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000518095 | SCV001928668 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000883099 | SCV001953248 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000518095 | SCV001969069 | benign | not specified | no assertion criteria provided | clinical testing |